Overview

The Military Rehabilitation and Compensation Act Treatment (Revocation) Determination Instrument No. M20 of 2004 was enacted in 2005 to address the practical challenges of applying the Determination for Providing Treatment under the Military Rehabilitation and Compensation Act 2004 (MRCA). This instrument aimed to improve the clarity and accessibility of treatment provisions for individuals entitled to benefits under the MRCA by revoking the previously complex Determination for Providing Treatment, which incorporated by reference the Treatment Principles, Repatriation Private Patient Principles, and Repatriation Pharmaceutical Benefits Scheme from the Veterans' Entitlements Act 1986 (VEA). The instrument was introduced by the Military Rehabilitation and Compensation Commission (MRCC) with the objective of streamlining the treatment provisions to better mirror the relevant VEA instruments and ensure uniformity in treatment entitlements for both MRCA and VEA beneficiaries. The revocation and subsequent re-making of these provisions into separate, stand-alone instruments was intended to eliminate the complexity and inefficiencies associated with the previous approach, thereby facilitating a more straightforward application of the treatment policies.

Scope and Application

The Military Rehabilitation and Compensation Act Treatment (Revocation) Determination Instrument No. M20 of 2004 serves to revoke the Determination for Providing Treatment previously made under the Veterans' Entitlements Act 1986, which had been applied to individuals entitled to treatment under the Military Rehabilitation and Compensation Act 2004. This revocation is necessitated by the complexity of the original Determination, which incorporated by reference the Treatment Principles, Repatriation Private Patient Principles, and Repatriation Pharmaceutical Benefits Scheme, necessitating a cumbersome process of interpretation in conjunction with the three Veterans' Entitlements Act Instruments. To streamline application and align with recent amendments to the VEA Instruments, the original Determination is replaced with three distinct instruments: one for medical and allied health treatment, one for private-patient hospital treatment, and one for pharmaceutical benefit treatment. This change aims to ensure consistency and simplify the application process for those entitled to treatment under the MRCA. The scope of this Instrument extends to individuals who are beneficiaries under the Military Rehabilitation and Compensation Act 2004, thereby ensuring they receive treatment on terms equivalent to those provided under the Veterans' Entitlements Act 1986. The revocation and subsequent creation of three separate instruments reflect a policy decision to mirror relevant health care provisions between the two Acts, ensuring uniformity in treatment entitlements. The Instrument applies nationally across Australia, impacting all persons entitled to treatment under the MRCA. No consultation was deemed necessary as the new instruments essentially replicate the content of the revoked Determination.

Key Provisions

The Military Rehabilitation and Compensation Act Treatment (Revocation) Determination Instrument No. M20 of 2004 (hereafter referred to as the Instrument) revokes MRCA Instrument No.3 of 2004 (Determination for Providing Treatment), which previously applied the Treatment Principles, the Repatriation Private Patient Principles, and the Repatriation Pharmaceutical Benefits Scheme (section 286 of the Military Rehabilitation and Compensation Act 2004 (MRCA)). The previous Determination was problematic because it incorporated by reference the Veterans' Entitlements Act 1986 (VEA) Instruments, making it difficult to apply without reading the VEA Instruments, which was laborious and time-consuming. To address this, the Instrument will be replaced with three separate "stand alone" Instruments that will cover the three treatments previously encompassed by the Determination: medical and allied health treatment, private-patient hospital treatment, and pharmaceutical benefit treatment. The Instrument imposes obligations on parties by revoking the previous Determination for Providing Treatment and creating three new separate Instruments that mirror the relevant VEA Instruments as closely as possible. This ensures that beneficiaries under both the VEA and the MRCA are entitled to treatment on the same terms. The new Instruments will provide clearer and more direct guidance on treatment conditions, making it easier for practitioners and claimants to understand and apply the provisions. There are no specific offences, penalties, or civil/criminal consequences mentioned for breach of the Instrument itself, as it is a revocation and restructuring exercise rather than a new regulatory framework. However, the new Instruments that replace the Determination will likely include provisions for compliance and enforcement, as well as penalties for non-compliance with the treatment conditions they establish. The penalties for breaches of the new Instruments would be in line with those specified under the relevant sections of the MRCA and VEA, although these are not detailed in the Instrument itself.